The Knowledge to Decide

The Dubai-based, ABV Group – a chain of luxury hospitals – has set its sights to establish luxury hospitals in India. These hospitals would offer personalized care and transportation in Rolls Royce for its patients – catering to the rich. . With just 50 suites and no option of shared rooms within a hospital, the promise of a crowd-free environment is quite alluring. Away from the glorified government hospitals norm, there will be no mixing between patients or long queues. Such initiatives aim to attract more medical tourists to the country as well as generate finances to drive charity initiatives. With approximately USD80 million in investments to execute this vision, the first luxury hospital will be operational in Mumbai by early 2017, followed by another in New Delhi. How will the rise of luxury hospitals change healthcare industry in India? https://www.spireresearch.com/newsroom/spirethoughts/india-to-witness-hospital-treatment-in-style/

Spire Research and Consulting collaborated with the Indonesian Business Data Center (PDBI) to study the direct economic impact of Indonesia’s National Health Insurance (JKN) program in 2015. The study revealed that the much talked about JKN program would add up to IDR18.62 trillion (USD1.3 billion) to Indonesia’s economy. Jeffrey Bahar, Deputy Chief Executive Officer of Spire Research and Consulting group, was honoured to address a press conference on behalf of PDBI on 25 August  2015 in Central Jakarta. During the conference, he discussed the direct economic impact of the JKN program since its implementation in 2014. Bahar opined that the positive impact highlights the contribution from four related sectors namely human resources, construction of hospitals, health services and medicines. Interestingly, the study used data from various government institutions throughout 2014 which clearly demonstrated that the JKN program has raised demand for doctors and nurses by 50,000

A new germ-zapping robot manufactured by Xenex in the U.S. could emerge as a saviour against deadly viruses like Ebola. It uses pulses of high-intensity, high-energy ultra-violet rays to crack bacterial cell walls and kill virus-afflicting pathogens. It has been successfully tested on 22 different microorganisms – destroying viruses similar to Ebola. Standing at 5 feet and bearing the nickname “Saul”, the ultra-violet rays it emits are 25,000 times brighter than fluorescent lights and can kill pathogens that are generally missed by the naked eye. A few surgical teams in the United States have been trained to use this technology on Ebola patients. According to research, hospitals with access to this technology have been able to bring down general infection rates by 60%. It is already being used in 250 hospitals. Can such technology breakthroughs arrest global pandemics in the 21st century? https://www.spireresearch.com/newsroom/spirethoughts/zapping-away-viruses/